US Map / South Carolina
State SC

Clinical Trials in South Carolina

South Carolina is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in South Carolina and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 172 actively recruiting studies with South Carolina sites out of 172 registered in total. The busiest research areas in South Carolina are Obesity, Overweight, Acute Myeloid Leukemia. Leading sponsors running trials in the state include Medical University of South Carolina, AstraZeneca, SWOG Cancer Research Network. By stage, South Carolina trials break down as Phase 1 (18), Phase 2 (43), Phase 3 (70), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
172
Recruiting Now
172
← Back to US Map
Top Conditions in South Carolina
Obesity (4)Overweight (3)Acute Myeloid Leukemia (3)Head and Neck Squamous Cell Carcinoma (3)Endometrial Cancer (3)Multiple Myeloma (2)Alpha 1-Antitrypsin Deficiency (2)Acute Kidney Injury (2)Focal Segmental Glomerulosclerosis (2)Myelofibrosis (2)Hypertension (2)Renal Insufficiency (2)

Frequently Asked Questions — Clinical Trials in South Carolina

How many clinical trials are currently recruiting in South Carolina?
ClinicalMetric currently tracks 172 actively recruiting clinical trials with at least one location in South Carolina. The total number of registered studies—including active but not currently enrolling trials—is 172. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in South Carolina?
South Carolina hosts clinical trials across a broad range of medical conditions, including Obesity, Overweight, Acute Myeloid Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout South Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in South Carolina?
To join a clinical trial in South Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in South Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in South Carolina

NCT05822388 N/A
Recruiting
Cognitive Decline Following Deep Brain Stimulation
Condition
Parkinson Disease
Enrollment
80 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07717892 Phase 3
Recruiting
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOC...
Condition
ADHD
Enrollment
468 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
View Trial →
NCT06830265 N/A
Recruiting
Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Comp...
Condition
Prostate Cancer Screening
Enrollment
200 pts
Location
United States
Sponsor
Uro-1 Medical
View Trial →
NCT06218875 N/A
Recruiting
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endopros...
Condition
AAA - Abdominal Aortic Aneurysm
Enrollment
2,000 pts
Location
United States, Australia, Austria
Sponsor
W.L.Gore & Associates
View Trial →
NCT07532265 Phase 2
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in...
Condition
Severe Asthma
Enrollment
512 pts
Location
United States
Sponsor
Kinaset Therapeutics Inc
View Trial →
NCT06516653 N/A
Recruiting
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistul...
Condition
End Stage Renal Disease
Enrollment
300 pts
Location
United States
Sponsor
Laminate Medical Technologies
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05125302 Phase 3
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets f...
Condition
Migraine
Enrollment
1,059 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT07684235 Phase 3
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of ...
Condition
Obesity
Enrollment
3,200 pts
Location
United States, Australia, Japan
Sponsor
Amgen
View Trial →
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT07477704 Phase 2
Recruiting
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult P...
Condition
Hypercholesterolemia
Enrollment
420 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06842498 Phase 2
Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate...
Condition
Metastatic Castration-Resistant Prostate Cancer
Enrollment
75 pts
Location
United States
Sponsor
Kyntra Bio
View Trial →
NCT07196748 Phase 3
Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Mode...
Condition
Colitis, Ulcerative
Enrollment
882 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
View Trial →
NCT06501625 Phase 1, Phase 2
Recruiting
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Pa...
Condition
Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
Enrollment
52 pts
Location
United States, Australia, Brazil
Sponsor
Institut de Recherches Interna
View Trial →
NCT06745908 Phase 3
Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhi...
Condition
NSCLC Stage IV
Enrollment
507 pts
Location
United States, Canada, United Kingdom
Sponsor
ImmunityBio, Inc.
View Trial →
NCT05899608 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
1,600 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
View Trial →
NCT07652658 Phase 2
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
359 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT06581328 Phase 4
Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in t...
Condition
Ulcerative Colitis
Enrollment
400 pts
Location
United States
Sponsor
Takeda
View Trial →
NCT05659381 Phase 3
Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary P...
Condition
Stage III Ovarian Cancer
Enrollment
220 pts
Location
United States
Sponsor
GOG Foundation
View Trial →
NCT06388967 N/A
Recruiting
Pancreatic Cancer Detection Consortium
Condition
Pancreatic Cancer
Enrollment
2,000 pts
Location
United States, Japan, South Korea
Sponsor
City of Hope Medical Center
View Trial →
NCT05034432 Phase 4
Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventri...
Condition
Arrythmia
Enrollment
100 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
View Trial →
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05263206 Phase 3
Recruiting
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Partici...
Condition
Pruritus
Enrollment
284 pts
Location
United States, Argentina, Canada
Sponsor
Sanofi
View Trial →
Page 2 of 7 — 172 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology